Bone Biologics Corporation
Bone Biologics Corporation (BBLG) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BBLG · as of Sep 30, 2025
Ownership Breakdown
7
Institutional Holders
▲ 3 vs Q2
$36,675
Total Inst. Value
▲ $34,842 vs Q2
1.80M
Shares Outstanding
freeFloat 99.96%
13,145
13F Shares Held
▲ 12,690 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BBLG largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 7 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DRW SECURITIES, LLC orthopedic, prosthetic & surgical appliances & supplies | 11.0K | 61.43% | 61.43% | $30.77M | Nov 14, 2025 | NEW |
TOWER RESEARCH CAPITAL LLC (TRC) orthopedic, prosthetic & surgical appliances & supplies | 1.5K | 8.16% | 8.16% | $4.08M | Nov 14, 2025 | ▲ 1.3K |
SBI SECURITIES CO., LTD. orthopedic, prosthetic & surgical appliances & supplies | 230 | 1.28% | 1.28% | $642,000 | Nov 5, 2025 | NEW |
CITIGROUP INC orthopedic, prosthetic & surgical appliances & supplies | 206 | 1.15% | 1.15% | $575,000 | Nov 10, 2025 | NEW |
CLEAR STREET GROUP INC. orthopedic, prosthetic & surgical appliances & supplies | 138 | 0.77% | 0.77% | $385,000 | Nov 14, 2025 | NEW |
UBS GROUP AG orthopedic, prosthetic & surgical appliances & supplies | 66 | 0.37% | 0.37% | $184,000 | Nov 13, 2025 | ▼ 47 |
BANK OF AMERICA CORP /DE/ orthopedic, prosthetic & surgical appliances & supplies | 14 | 0.08% | 0.08% | $39,000 | Feb 3, 2026 | ▲ 10 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
2
Increased
+1.3K shares4
New Positions
first time holders1
Decreased
−47 shares0
Sold Out
fully exitedNet shares change (top 50)
+1.2K
+1.3K / −47
Net new holders
+5
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BBLG insider trading · insider activity
Source: SEC Form 4
4
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Walsh Deina H Chief Financial Officer | Jan 8, 2026 | Award | 8,335 | $1.55 | $12.9K | 8.3K | Form 4 ↗ |
Frelick Jeff Chief Executive Officer | Jan 8, 2026 | Award | 16,668 | $1.55 | $25.8K | 16.7K | Form 4 ↗ |
Meikle Phillip Terry II director | Jun 4, 2025 | Award | 62,894 | $0.88 | $55.3K | 62.9K | Form 4 ↗ |
Angle Siddhesh Rajendra director | Jun 4, 2025 | Award | 62,894 | $0.88 | $55.3K | 62.9K | Form 4 ↗ |
Stroever Bruce director | Jun 4, 2025 | Award | 62,894 | $0.88 | $55.3K | 62.9K | Form 4 ↗ |
Gagnon Robert E. director | Jun 4, 2025 | Award | 62,894 | $0.88 | $55.3K | 62.9K | Form 4 ↗ |
Frelick Jeff Chief Executive Officer | Jan 15, 2025 | Award | 54,110 | $0.97 | $52.4K | 54.1K | Form 4 ↗ |
Walsh Deina H Chief Financial Officer | Jan 15, 2025 | Award | 27,055 | $0.97 | $26.2K | 27.1K | Form 4 ↗ |
Meikle Phillip Terry II director | Oct 16, 2024 | Award | 28,185 | $1.88 | $53.0K | 28.2K | Form 4 ↗ |
Meikle Phillip Terry II director | Oct 16, 2024 | Award | 9 | $1.88 | $16.92 | 9 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bone Biologics Corporation (BBLG) is primarily owned by institutional investors, who hold approximately 0.7% of total shares outstanding. Company insiders own approximately 0.04%, while retail and public investors account for the remaining 99.23%.
The largest institutional shareholder of Bone Biologics Corporation is DRW SECURITIES, LLC, holding approximately 11,027 shares — equal to 61.43% of outstanding shares — as of September 30, 2025.
A total of 7 institutional investors currently hold BBLG stock, with a combined institutional value of approximately $36,675 as of the most recent 13F filing period.
Frequently asked questions
BBLG ownershipBone Biologics Corporation (BBLG) is primarily owned by institutional investors, who hold approximately 0.7% of shares. The largest shareholder is DRW SECURITIES, LLC with a 61.43% stake. Company insiders hold 0.04%. Data sourced from SEC Form 13F as of September 30, 2025.